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1. Introduction 
A large number of fucose containing substances, 
chemically characterized asoligosaccharides, glyco- 
proteins or glycolipids have been isolated from cells, 
tissues or fluids of various animal species including 
those of human, bovine, pig, dog and rat [1-7] .  
The fucose is found to be attached to carbohydrate 
residues by at least three distinct ypes of glycosidic 
bonds. In the first L-fucose is t~-(l~2) linked to a 
fl-galactose unit by the action of the blood group 
H-dependent gene product. In human, this enzyme 
has been described in a soluble form in milk and 
serum [8-11] and in particulate form in stomach 
mucosa, submaxillary glands and bone-marrow [ 12,13]. 
The L-fucose residue is also found a-(I-->4) linked 
to a subterminal N-acetyl-D-glucosamine. Thecorres- 
ponding enzyme is recognized as the Lewis gene pro- 
duct and was demonstrated among Le individuals in 
milk, submaxillary glands, stomach mucosa [8,12-14] 
but not in serum or plasma [9,10]. In the third type, 
L-fucose is linked to the C-3 position of the sub- 
terminal N-acetyl-D-glucosamine, the addition being 
catalysed by a 3-ct-L-fucosyltransferase found up to 
now in all human individuals [8-12].  
However, other fucosyltransferases arevery likely 
to occur because some compounds with L-fucose 
linked a-( l~3) or ct-(1-->6) to N-acetylglucosamine or 
/3-galactose r sidues also have been described [15-17]. 
In secretory tissues uch as submaxillary glands or 
stomach mucosa, the synthesis of the H enzyme 
(2-~-L-fucosyltransferase) is controlled by a second 
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gene, termed secretor gene Se [12]. It has been shown 
that milk from non-secretor sese individuals is devoid 
of H enzyme activity [8]. In serum or bone-marrow 
however, the H enzyme is always found, whatever the 
secretor status [9,13]. The only exceptions are the 
serum from rare 'Bombay' individuals thought o be 
homozygotes for a recessive h gene [9,18-20]. The 
A, B or H substances are absent from both red cells 
and secretions of these individuals, while their plasma 
always contain the anti-A, -B, and -H agglutinins. 
These findings are certainly among the most important 
which support he biosynthetic pathway of A and B 
blood group substances predicted by Morgan and 
Watkins [21] because the H substance is considered to 
be the biochemical precursor of A and B. 
In addition to the 'Bombay' blood samples, some 
individuals whose red cells express A and B antigens, 
but no H, have been described [22-24]. Following 
Race and Sanger [25] these people were named 
'Parabombay'. The purpose of this paper was there- 
fore to investigate the H enzyme activity in serum 
and red cell membranes from 'Bombay' and 'Para- 
bombay' individuals. When necessary, the A and B 
blood group glycosyltransferases w re simultaneously 
estimated. As a preliminary step in this work, the H 
enzyme activity from common blood samples was 
also studied as a function of their ABO phenotypes. 
2. Materials and methods 
Sera from Al, A2, AIA2, A1B, A2B, B I, BII, 0 and 
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Bombay donors were collected and stored at -20°C 
until used. 
Red cell ghosts from normal (A1, A2, A1B, B, O) 
and Bombay cells were prepared according to Dodge 
et al. [26], and the protein content of the red cell 
membrane suspensions was estimated with the Folin 
Ciocalteu reagent [27]. 
Guanosine diphospho-L-[U:4C] fucose (153 mCi/ 
mmol) purchased from the Radiochemical Centre 
(Amersham) was used in 2% ethanolic solution. 
UDP-N-acetyl-D- [ 1:4C] galactosamine (47.2 mCi/ 
mmol) and UDP-D-[14C] galactose (274 mCi/mmol) 
obtained from Nen Chemicals (Frankfurt) were 
respectively used in 50% and 2% ethanolic solution. 
Lacto-N-Biose I (O-/3-D-galactopyranosyl (1-+3)- 
N-acetyl-D-glucosamine) wasa gift from Professors 
Lemieux and Gauhe. It was either chemically 
synthesized orextracted from human milk. 2'-Fuco- 
syllactose (O-ct-L-fucopyranosyl (l~2)-O-/3-D-galacto- 
pyranosyl-(1-->4)-D-glucopyranose) was extracted from 
human milk. 
Enzyme assays in human sera: 
A and B enzyme assays have been described [28,29]. 
H enzyme assays were carried out in total vol. 55/21 
with the following components: erum, 25/21; Tris- 
HC1, pH 7.2, 2/2mol; MgCI2, 0.5/2mol; GDP-[~4C] - 
fucose, 0.92 nmol; NAN3, 1/2mol; Lacto-N-Biose I,
100/2g; ATP, 0.64/2mol. The mixture was incubated 
for 72 h at 37°C. 
Enzyme assays in RBC ghosts: 
A and B enzymes in erythrocyte membrane were 
estimated as described by Cartron et al. [30]. The 
2~-L-fucosyltransferase from RBC was performed 
by adding the following components in total vol. 
160/A: 500-1000/2g erythrocyte membrane protein; 
Tris-HC1 buffer pH 7.2, 8/2mol; MgC12, 2/2mol; GDP- 
[14C]fucose, 184 nmol; NAN3, 1/2mol; Lacto-N-Biose 
I, 200/2g; ATP 2.58/2mol and 5/21 of Triton X-100 
10% (v/v). The mixture was incubated for 72 h at 
37°C. 
The ct-L-fucosidase activity of normal, 'Bombay' 
and 'Parabombay' sera was tested as described by 
Ramage t al. [31]. 
Characterisation f H enzymatic product: 
The trisaccharide a-L-Fuc (1-->2) Gal/3 (1-+3) G1NAc 
synthesized by addition of L- [ ~4C] fucose into Lacto- 
N-Biose I was characterized after high voltage lectro- 
phoresis in 0.1 M ammonium formate buffer, pH 3.5 
(Whatman paper No. 40; 2000 V, 100 mA, 2 h) and 
descending chromatography in ethylacetate/pyridine/ 
acetic acid/water (5:5:1:3). The REact was 1,03 in 
this solvent. 
3. Results and discussion 
Lacto-N-Biose I was used as a convenient low molec- 
ular weight acceptor for H enzyme assays, because: 
(i) The 4-a-Dfucosyltransferase activity of human 
sera is negligible. 
(ii) This sugar is not a substrate for the very common 
3-a-L-fucosyltransferase [9].
Accordingly, the L-fucose incorporated is almost 
exclusively a-(l~2) linked to the terminal/3-galactose 
residue of Lacto-N-Biose I. This compound was identified 
by its chromatographic mobility. 
3.1.2-a-L-fucosyltransferase lev ls in blood samples 
110 sera were studied including 16 AI, 17 A2, 14 O, 
17 A1B, 16 A2B, 10 BI, 10 BII and 10 AIA2, the 
latter being identified by the pH ratio dependent curve 
of the A gene product [32]. The enzyme activity was 
found in all sera either from secretor or non-secretor 
individuals, suggesting that the serum enzyme does not 
originate from mucous ecretory tissues. The mean 
values observed within each ABO blood group are 
reported in table I, but a more interesting pattern 
was noticed when all the results were plotted (fig,l). 
In spite of a large overlap between each group, the H 
enzyme activity was found on the average to be higher 
in A1A2, A1, A1B and As sera than in O, A2B or B 
(B I and BII are subgroups defined by Badet et al. [28] 
according to the level of the serum a-D-galactosyl- 
transferase). This finding was also recently reported 
by Chester et al. [33]. The results uggest some kind 
of reciprocal relationship between the H enzyme level 
of the serum and the H antigenic ontent of the red 
cells. It was however verified that such a gradient of 
H blood group enzyme activity was not correlated 
with a fucosidase activity or with the A or B enzyme 
levels of the sera. The mean release of paranitrophenol 
from PNP-t~-L-fucopyranoside wasequal to 2.13, 
2.08, 1.74, 2.37, 2.99, 2.82 and 2.23/2mol/min/litre 
in the A1A:, A1, AIB, A2, O, A2B and B sera described 
above. Large variations of the fucosidase activity were 
also noticed within a group (not shown). Moreover, 
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Table 1 
ABH blood group enzyme activities in sera and RBC ghosts from common ABH donors 
December 1977 
Activity of blood group glycosyltransferases 
In RBC ghosts Genotype In serum 
A a (pH 6.0) A 2 (pH 7.0) B H A B H 
O - - - 7044 (14) - - 5530 (2) 
At a 28 000 (16) - - 9380 (16) 64 200 (1) 0 5690 (1) 
A2b _ 16 419 (17) - 8491 (17) 10 800 (1) 0 4500 (1) 
A1B 25 372 (14) - 11480(14) 9107 (17) 52 925 (2) 31 700 (2) 4920 (2) 
A2B - 12 751 (16) 8248 (16) 6445 (16) - - - 
A~A 2 29 198 (9) 24 548 (9) - 11 392 (10) - - - 
B I - - 5820 (10) 6313 (10) - 73 430 (2) 5775 (2) 
BII - - 12 300 (10) 4876 (10) 
aMaximum A enzyme activity at pH 6.0 in A 1 sera 
bMaximum A enzyme activity about pH 7.0 in A 2 sera 
Enzyme activities are expressed in cpm of radiolabelled sugar incorporated into appropriate acceptors as described in 
Methods. Values in brackets indicate the number of samples tested 
incubat ion at neutral pH of the purified radiolabelled 
H trisaccharide with several samples of sera (37°C for 
72 h) did not demonstrate any release of  [14C] fucose. 
Lastly, the differences of H enzyme levels in sera were 
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Fig.1. Incorporation of  L-[14C]fucose into Lacto-N-Biose I 
by serum samples from donors of  different ABO groups as 
shown on abscissa. (e) Mean enzyme activity. 
not related to A or B glycosyltransferase activities. 
Therefore, the relationship between H enzyme 
activity and ABO phenotype remains unclear mainly 
because the origin of the serum enzyme is not known. 
Among the possible hypotheses one may consider 
that the enzyme is, for some unknown reason, partly 
inactivated at the site of its biological function. Such 
results however must be borne in mind if attempts 
are made for quantitative estimations of H enzyme 
level. 
The 2-a-L-fucosyltransferase ctivity was more 
homogeneous in red cell membranes from eight donors 
including 2 O, 1 A1, 1 A2, 2 B and 2 AB individuals, 
among which, three were not secretors. The H enzyme 
is membrane bound in these preparations, and maxi- 
mum activity is obtained only by addition of Triton 
X-100. The relationship with ABO phenotypes of 
RBC was not found, but only a small number of 
samples have been investigated. 
However, the heterogeneity of H enzyme activity 
in sera may also result from the contributions of 
unidentif ied cells secreting transferase in the blood 
stream. 
The A and B enzyme activities of the RBC mem- 
brane were higher than the H activity, but it is possible 
that better results could be obtained using other 
detergents for membrane solubilisation [4]. 
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3.2. Serum and red cell ABH glycosyltransferase in 
'Bombay' and 'Parabombay' individuals 
As previously described by Race and Watkins 
[18,19] and Schenkel-Brunner t al. [9], the sera 
B from 'Bombay'  people Oh, O A, O h were devoid 
of  H enzyme activity. We have furthermore demon- 
strated that the H enzyme is also deficient in the 
red cell stroma of  the 7 individuals tested (table 2). 
These expected results suggest either that the hypo- 
thetical h gene is amorph or that it controls the 
synthesis of  a catalytically inactive protein. The true 
genotype of these rare individuals may however be 
deduced from the simultaneous investigations of  the 
A and/or B glycosyltransferase, always active in sub- 
jects with the appropriate blood group. 
Similar results have been obtained with the nine 
'Parabombay' blood samples Ah, B h and AB h, namely: 
(i) Absence of  detectable 2-a-L-fucosyltransferase 
activity in serum and RBC membranes. 
(ii) Normal amount of  A and/or B serum and RBC 
enzyme activity in accordance with ABO pheno- 
type (table 2). 
The results demonstrate that the weak A and/or B 
antigenic ontent of  the Ah, B h or AB h red cells is not 
related to abnormal synthesis of  A and/or B glycosyl- 
transferase but rather to a l imited product ion of  the 
blood group H precursor. It is usually admitted that 
the small amount of  the A and/or B antigens on 
Parabombay red cells is built on the few H determi- 
nants produced by poorly active variants of  the H gene. 
In such samples, a weak H enzyme activity is expected 
but was not found, may be due to the rather insensi- 
tive method of  assay. It is possible that the phenyl- 
/3-galactoside would be a more suitable substrate when 
a low H enzyme activity is expected [33]. 
Some workers have suggested an alternative bio- 
synthetic pathway which would make possible the 
product ion of  A and B antigen independently of  the 
Table 2 
ABH blood group enzyme activities in sera and RBC ghosts from 'Bombay' and 'Parabombay' individuals 
Sample Genotype a In serum In RBC ghosts 
A 1 A 2 B H A B H 
(pH 6.0) (pH 7.0) 
Bombay 
SCH 0 0 b 0 0 0 - - 0 
MART c 0 0 0 0 0 - - - 
BEN A t 52 700 30 300 0 0 - - - 
GER A 1 48 400 36 400 0 0 100 700 - 0 
LEN A 1 41 700 32 100 0 0 21 100 - 0 
JOS AIB 24 000 20 200 11 100 0 49 900 14 600 0 
AFS (No. 3) c B 0 0 4200 0 - - - 
Parabombay 
BEG c A 1 20 130 11 800 0 0 - - - 
OTT A 1 30 700 17 275 0 0 81 300 - 0 
GEO c A 2 18 700 28 500 0 0 8000 0 0 
JES A 2 13 200 27 200 0 0 10 800 - 0 
DIJ A2B 11 400 27 500 7900 0 - - - 
MARA AIB 31 200 18 500 12 000 0 107 200 82 100 0 
CER B 0 0 15 000 0 - 150 000 0 
TUP B 0 0 36 120 0 - 117 800 0 
PAY B 0 0 34 070 0 - 66 200 0 
aGenotype deduced from either family or enzyme studies 
bNo detectable enzyme activity 
CSaliva not tested for ABH substances 
Enzyme activities are expressed in cpm of radiolabelled sugar incorporated into appropriate acceptors as 
described in Methods 
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usual H precursor [23,34]. This concept is however 
entirely speculative and it is not up to now supported 
by any experimental evidence. 
The study of other H variants characterized by a 
selective decrease of the H receptors on RBC and 
normal amount of salivary substances (Hm phenotypes) 
is actually in progress. It may provide further infor- 
mation both on the nature of the antigenic defect 
and the origin of serum 2-a-L-fucosyltransferase. 
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